BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29858589)

  • 1. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study.
    Li WM; Pasaribu N; Lee SS; Tsai WC; Li CY; Lin GT; Chuang HY; Tung YC; Tu HP
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):277-286. PubMed ID: 29858589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study.
    Man KM; Chen KB; Chen HY; Chiang JH; Su YC; Man SS; Xie DD; Wang Y; Zhang ZQ; Bi LK; Zhang T; Yu DX; Chen WC
    Medicine (Baltimore); 2018 Sep; 97(39):e12459. PubMed ID: 30278528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
    Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
    Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan.
    Ou SC; Huang ST; Lin MC; Chen WC; Huang CP; Lin HJ
    Int J Urol; 2022 Jul; 29(7):623-630. PubMed ID: 35486019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of alpha-1-adrenergic antagonist use with the risk of gout development in benign prostatic hyperplasia patients: a population-based cohort study.
    Hsu WH; Lai JN; Lin CL; Loh CH; Huang HK; Huang LK
    Fam Pract; 2022 May; 39(3):426-431. PubMed ID: 34964888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia.
    Shih HJ; Huang CJ; Lin JA; Kao MC; Fan YC; Tsai PS
    Prostate; 2018 Feb; 78(2):113-120. PubMed ID: 29119583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of atrial fibrillation in patients with benign prostatic hyperplasia: A population-based cohort study.
    Hu WS; Lin CL
    Clin Cardiol; 2018 Oct; 41(10):1374-1378. PubMed ID: 30144121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
    Tseng CH
    BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Gout and Incident Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
    Tung YC; Lee SS; Tsai WC; Lin GT; Chang HW; Tu HP
    Am J Med; 2016 Nov; 129(11):1219.e17-1219.e25. PubMed ID: 27448491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of incident gout in kidney transplant recipients: A retrospective cohort study.
    Simbolon FR; Lee SS; Tsai YC; Tsai WC; Lin GT; Tung YC; Tu HP
    Int J Rheum Dis; 2018 Nov; 21(11):1993-2001. PubMed ID: 30338664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study.
    Peng YH; Huang CW; Liao WC; Chen HJ; Yin MC; Huang YM; Wu TN; Ho WC
    BMJ Open; 2017 Jun; 7(6):e015581. PubMed ID: 28645971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of benign prostatic enlargement among patients with liver cirrhosis: a nationwide population-based study.
    Chung SD; Lin HC
    J Androl; 2011; 32(2):159-64. PubMed ID: 20798385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Erectile Dysfunction and Subsequent Prostate Cancer Development: A Population-Based Cohort Study With Double Concurrent Comparison Groups.
    Kok VC; Hsiao YH; Horng JT; Wang KL
    Am J Mens Health; 2018 Sep; 12(5):1492-1502. PubMed ID: 29708021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
    Fang CW; Liao CH; Wu SC; Muo CH
    World J Urol; 2018 Jun; 36(6):931-938. PubMed ID: 29427001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout patients have an increased risk of developing most cancers, especially urological cancers.
    Chen CJ; Yen JH; Chang SJ
    Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.
    Lin TY; Chen IH; Weng HY; Lin YC; Ou CH; Li CY; Cheng YS
    World J Urol; 2024 Mar; 42(1):126. PubMed ID: 38460003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Risk of Benign Prostate Hyperplasia (BPH) in Patients with Gout: A Longitudinal Follow-Up Study Using a National Health Screening Cohort.
    Bang WJ; Choi HG; Kang HS; Kwon MJ; Kim JH; Kim JH; Kim SY
    Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.